MJH Life Sciences officially launched Medical World News, a first-of-its-kind 24-hour news program offering insights on the latest news in health care.
LabCorp’s Covance drug development business launched COVID-19 Clinical Trial Connect in the U.S. to help people find information on taking part in clinical trials.
One day after Bristol Myers Squibb announced the commercial launch of the multiple sclerosis drug Zeposia (ozanimod), the company said the medication demonstrated statistically significant efficacy as a potential induction and maintenance therapy for ulcerative colitis.
COVID-19 has changed nearly every aspect of healthcare as we know it. Pharmaceutical commercial organizations must quickly adapt to the present while simultaneously planning for a dramatically different future.
Eli Lilly is moving quickly to get the newly approved precision oncology treatment Retevmo for certain lung and thyroid cancers into the hands of patients.
Cambridge, Massachusetts-based Dyno Therapeutics came out of stealth mode with an official launch of the company’s proprietary CapsidMap platform.
Shares of New York-based Stemline Therapeutics skyrocketed more than 153 percent in trading after Italy’s Menarini Group announced a $667 million acquisition of the oncology-focused company.
Deaf-owned software company Wavio announced a strategic partnership with AREA 23, an FCB Health Network Company, which includes a major investment deal for the development and product launch of “See Sound.” Created by AREA 23 and Wavio, the revolutionary home device is scheduled to launch during 2020. The partnership provides the FCB Health Network with company equity in Wavio and revenue share on product sales.
PSA Features New Song from Alicia Keys, ‘Good Job’ New York, NY (April 27, 2020) – To thank those on the front lines of the COVID-19 pandemic, the Ad […]
Swiss pharma giant Roche joined the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease.
